Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

China Biologic Products, Inc. (CBPO): Warburg Pincus Sells Shares to Underwriter

Warburg Pincus has just filed a Form 13D with the SEC, updating the regulatory body on the latest pertinent information related to its position in China Biologic Products Inc (NASDAQ:CBPO). The activist filing reveals that the investment firm has sold over half of its stake in the company since the end of 2015, when it held 8.34 million shares. The firm now owns 4.09 million shares of the issuer.

Item 4 of the filing was updated with the following information related to the recent large sale of shares:

“On March 4, 2016, the Underwriter notified the Funds of its election to exercise the option to purchase additional Shares from the Funds in full.

On March 7, 2016, the Funds sold an aggregate of 4,257,000 Shares to the Underwriter at a price of $107.00 per Share pursuant to the Underwriting Agreement.”

Shares of CBPO currently trade at $109.28 and are down by 23% this year.

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
WP X Biologics 0 3,112,920 0 3,112,920 3,112,920 11.7%
Warburg Pincus Private Equity X 0 3,960,496 0 3,960,496 3,960,496 14.9%
Warburg Pincus X Partners 0 126,704 0 126,704 126,704 0.5%
Warburg Pincus X 0 4,087,200 0 4,087,200 4,087,200 15.4%
Warburg Pincus X GP 0 4,087,200 0 4,087,200 4,087,200 15.4%
WPP GP 0 4,087,200 0 4,087,200 4,087,200 15.4%
Warburg Pincus Partners 0 4,087,200 0 4,087,200 4,087,200 15.4%
Warburg Pincus Partners GP 0 4,087,200 0 4,087,200 4,087,200 15.4%
Warburg Pincus Co 0 4,087,200 0 4,087,200 4,087,200 15.4%
Warburg Pincus 0 4,087,200 0 4,087,200 4,087,200 15.4%
Charles R. Kaye 0 4,087,200 0 4,087,200 4,087,200 15.4%
Joseph P. Landy 0 4,087,200 0 4,087,200 4,087,200 15.4%

Page 1 of 17 SEC Filing



Washington, D.C. 20549




Under the Securities Exchange Act of 1934

(Amendment No. 15)*



Biologic Products, Inc.

(Name of Issuer)

Common Stock, $0.0001 par value per share

(Title of Class of Securities)


(CUSIP Number)

Robert B. Knauss

Managing Director and General Counsel

Warburg Pincus LLC

Lexington Avenue

New York, NY 10017

(212) 878-0600

With a copy to:

Weiheng Chen, Esq.

Wilson Sonsini Goodrich & Rosati, P.C.

Suite 1509, 15/F, Jardine House

1 Connaught Place, Central

Hong Kong

+(852) 3972

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

March 7, 2016

(Date of
Event Which Requires Filing of This Statement)



If the filing
person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following
box.  ¨

Follow China Biologic Products Inc. (NASDAQ:CBPO)
Trade (NASDAQ:CBPO) Now!

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.